📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Prodesse

1.1 - Company Overview

Prodesse Logo

Prodesse

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of molecular diagnostic reagents for infectious disease applications, with three FDA 510(k) cleared products in the United States and two CE-marked products in Europe; products can be used with various nucleic acid extraction and real-time PCR.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Prodesse

Aethlon Medical Logo

Aethlon Medical

HQ: United States Website
  • Description: Provider of immunotherapeutic technologies to combat infectious disease and cancer, including the Hemopurifier, a device designed to rapidly remove cancer-promoting exosomes and circulating viruses from the bloodstream, currently under clinical trials for various cancers and viral infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aethlon Medical company profile →
AN2 Therapeutics Logo

AN2 Therapeutics

HQ: United States Website
  • Description: Provider of boron chemistry–based drug discovery and clinical development for infectious diseases, including epetraborole, an oral therapy in development for chronic non-tuberculous mycobacterial lung disease targeting Mycobacterium avium complex, and conducting clinical trials to obtain regulatory approval for new medications for infectious diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AN2 Therapeutics company profile →
Cubist Logo

Cubist

HQ: United States Website
  • Description: Provider of biopharmaceutical products focused on the research, development, and commercialization of therapies addressing unmet medical needs in the acute care environment; markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cubist company profile →
Sequella Logo

Sequella

HQ: United States Website
  • Description: Provider of biopharmaceutical products for diagnosing and treating epidemic infectious diseases, including SQ109 (Phase 2 for multidrug-resistant pulmonary tuberculosis), Sutezolid (oxazolidinone in clinical development for tuberculosis), SQ609 (preclinical for tuberculosis), SQ641 (preclinical for C. difficile and nontuberculous mycobacteria), B-SMART rapid TB susceptibility tests, and small-molecule and natural product drug discovery programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sequella company profile →
PBD Biotech Logo

PBD Biotech

HQ: United Kingdom Website
  • Description: Provider of clinical-stage phage-based diagnostics for tuberculosis, developing Actiphage TB, a blood-based test that detects Mycobacterium tuberculosis, supporting latent TB screening, active infection detection, and drug management.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PBD Biotech company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Prodesse

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Prodesse

2.2 - Growth funds investing in similar companies to Prodesse

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Prodesse

4.2 - Public trading comparable groups for Prodesse

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Prodesse

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Prodesse

What does Prodesse do?

Prodesse is a provider of molecular diagnostic reagents for infectious disease applications, with three FDA 510(k) cleared products in the United States and two CE-marked products in Europe; products can be used with various nucleic acid extraction and real-time PCR.

Who are Prodesse's competitors?

Prodesse's competitors and similar companies include Aethlon Medical, AN2 Therapeutics, Cubist, Sequella, and PBD Biotech.

Where is Prodesse headquartered?

Prodesse is headquartered in United States.

How many employees does Prodesse have?

Prodesse has 1,000 employees 🔒.

When was Prodesse founded?

Prodesse was founded in 2010 🔒.

What sector and industry vertical is Prodesse in?

Prodesse is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Prodesse

Who are the top strategic acquirers in Prodesse's sector and industry

Top strategic M&A buyers and acquirers in Prodesse's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Prodesse?

Top strategic M&A buyers groups and sectors for Prodesse include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Prodesse's sector and industry vertical

Which are the top PE firms investing in Prodesse's sector and industry vertical?

Top PE firms investing in Prodesse's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Prodesse's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Prodesse's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Prodesse's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Prodesse include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Prodesse's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Prodesse?

The key public trading comparables and valuation benchmarks for Prodesse include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Prodesse for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Prodesse with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Prodesse's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Prodesse with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Prodesse's' sector and industry vertical?

Access recent funding rounds and capital raises in Prodesse's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Prodesse